Aurora Cannabis Stock Forecast, Price & News

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last twelve months. There are currently 2 sell ratings and 6 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Aurora Cannabis stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ACB, but not buy additional shares or sell existing shares.
View analyst ratings for Aurora Cannabis or view top-rated stocks.

8 brokers have issued 12-month target prices for Aurora Cannabis' stock. Their ACB stock forecasts range from C$1.85 to C$7.50. On average, they anticipate Aurora Cannabis' share price to reach C$3.68 in the next year. This suggests a possible upside of 106.6% from the stock's current price.
View analysts' price targets for Aurora Cannabis or view top-rated stocks among Wall Street analysts.

Aurora Cannabis' stock was trading at C$6.85 at the start of the year. Since then, ACB stock has decreased by 74.0% and is now trading at C$1.78.
View the best growth stocks for 2022 here.

Aurora Cannabis is scheduled to release its next quarterly earnings announcement on Monday, September 26th 2022.
View our earnings forecast for Aurora Cannabis.

Aurora Cannabis Inc. (TSE:ACB) posted its quarterly earnings data on Monday, May, 15th. The company reported ($0.01) EPS for the quarter, hitting the consensus estimate of ($0.01). The company earned $5.18 million during the quarter, compared to analysts' expectations of $7.44 million.
View Aurora Cannabis' earnings history.

Some companies that are related to Aurora Cannabis include Canopy Growth (WEED), Hydropothecary (THCX), Knight Therapeutics (GUD), Amryt Pharma (AMYT), OrganiGram (OGI), HLS Therapeutics (HLS), Benchmark (BMK), Supreme Cannabis (FIRE), ESSA Pharma (EPI), ICC Labs (ICC), Leaf Mobile (LEAF), Medexus Pharmaceuticals (MDP), HEXO (HEXO), BioSyent (RX) and Green Organic Dutchman (TGOD).
View all of ACB's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Aurora Cannabis investors own include (CGC), Canopy Growth (WEED), Aphria (APHA), OrganiGram (OGI), Aurora Cannabis (ACBFF), Cronos Group (CRON), Micron Technology (MU), Alibaba Group (BABA), Green Organic Dutchman (TGOD) and Advanced Micro Devices (AMD).

Aurora Cannabis trades on the Toronto Stock Exchange (TSX) under the ticker symbol "ACB."

Shares of ACB and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

One share of ACB stock can currently be purchased for approximately C$1.78.

Aurora Cannabis (TSE:ACB) has a market capitalization of C$529.99 million and generates C$225.95 million in revenue each year.

Aurora Cannabis employs 1,761 workers across the globe.

Aurora Cannabis' mailing address is 1500 - 1199 West Hastings St., VANCOUVER, BC V6E 3T5, Canada. The official website for Aurora Cannabis is auroramj.com. The company can be reached via phone at +1-604-3625207.